GSK PLC (GSK)
Clinical trial NCT05690841 updates: 1. collaborators added: Medicines for Malaria Venture, Universidad Peruana Cayetano Heredia, GlaxoSmithKline 2. collaborators removed: Universidad Peruana Cayetano Heredia- subcontractor to UCSF as local Sponsor
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical